Persistent Asset Partners »

Newamsterdam Pharma Co Nv shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $139k 3.9k 35.08

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
RA Capital Management
Capital World Investors
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
FMR
Viking Global Investors
Deerfield Management Company
Wellington Management Company
Jennison Associates
Duquesne Family Office
Medicxi Ventures Management
Polar Capital Holdings
Adage Capital Partners GP
Alliancebernstein

View all funds holding Newamsterdam Pharma Co Nv